Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

3.460 -0.010 (-0.29%)
Streaming Delayed Price Updated: 9:34 AM EDT, Aug 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
News headline image
GoodRx Reports First Quarter 2026 Results
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect
Healthcare tech company GoodRx (NASDAQ:GDRX) will be announcing earnings results this Wednesday afternoon. Here’s what to look for. GoodRx beat analysts’ rev... 
Via StockStory
Topics Artificial Intelligence
News headline image
Why GoodRx (GDRX) Stock Is Trading Up Today
What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 9.5% in the afternoon session after it announced it would provide access to Novo... 
Via StockStory
Topics Artificial Intelligence
News headline image
GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients
From GoodRx
Via Business Wire
News headline image
Healthcare Technology Stocks Q4 Recap: Benchmarking GoodRx (NASDAQ:GDRX)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare techno... 
Via StockStory
GoodRx Holdings Inc (NASDAQ:GDRX) Stock Falls on Cautious 2026 Revenue Outlook ↗
Via Chartmill
News headline image
1 Cash-Producing Stock with Exciting Potential and 2 We Ignore
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
3 Reasons GDRX is Risky and 1 Stock to Buy Instead
GoodRx’s stock price has taken a beating over the past six months, shedding 40.7% of its value and falling to $2.31 per share. This was partly due to its sof... 
Via StockStory
Topics Supply Chain
News headline image
Why GoodRx (GDRX) Stock Is Up Today
What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 3.6% in the afternoon session after the company announced it now offers access t... 
Via StockStory
News headline image
GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price
From GoodRx
Via Business Wire
News headline image
GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide
From GoodRx
Via Business Wire
News headline image
1 Healthcare Stock on Our Watchlist and 2 We Avoid
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on... 
Via StockStory
News headline image
1 Value Stock with Exciting Potential and 2 Facing Challenges
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
News headline image
2 Small-Cap Stocks with Competitive Advantages and 1 That Underwhelm
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
News headline image
GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications
From GoodRx
Via Business Wire
News headline image
Option Care Health, CooperCompanies, Neogen, GoodRx, and Fortrea Shares Are Falling, What You Need To Know
Via StockStory
Topics Economy
News headline image
GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen®
From GoodRx
Via Business Wire
News headline image
PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. The Producer Price Index (PPI), a key... 
Via StockStory
Topics Economy Government Stocks
News headline image
GoodRx (GDRX) Q4 2025 Earnings Call Transcript ↗
GoodRx (GDRX) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Bankruptcy Earnings
News headline image
GoodRx’s (NASDAQ:GDRX) Q4 CY2025 Sales Top Estimates But Stock Drops 11.8%
Healthcare tech company GoodRx (NASDAQ:GDRX) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.9% year on year to $194.8 million. On the other hand, the... 
Via StockStory
Top movers in Wednesday's after hours session ↗
Via Chartmill
News headline image
GoodRx Reports Fourth Quarter and Full Year 2025 Results
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct”
From GoodRx
Via Business Wire
News headline image
GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect
Healthcare tech company GoodRx (NASDAQ:GDRX) will be announcing earnings results this Wednesday after the bell. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know
A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court... 
Via StockStory
Topics Government World Trade
News headline image
GoodRx (GDRX): Buy, Sell, or Hold Post Q3 Earnings?
GoodRx’s stock price has taken a beating over the past six months, shedding 56.5% of its value and falling to $2.23 per share. This was partly due to its softer quarterly results and may have investors... 
Via StockStory
Topics Supply Chain
News headline image
1 Healthcare Stock with Promising Prospects and 2 Facing Challenges
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and... 
Via StockStory
Topics Stocks
News headline image
Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings. ↗
There's another fight brewing around GLP-1 drugs -- this time on the delivery side. 
Via The Motley Fool
News headline image
GoodRx Powers Pricing for Leading Brand Medications on TrumpRx
From GoodRx
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.